CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39,374 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06097494
NCT06097494N/ACompleted

Healthcare Disparities in Vitiligo: a Population-based Cohort Study in the UK

Momentum Data·observational·Posted Oct 24, 2023·Updated Mar 17, 2025

In Brief

An observational study evaluating No intervention for Vitiligo. Completed, enrolled 39,374 participants across 1 site.

Detailed Summary

Vitiligo is an acquired, non contagious skin disorder characterised by depigmented patches of skin that may appear in a localised or very generalised distribution, and affecting 0.5-2.0% of the global population.There are however, limited population-based studies on the burden of vitiligo and disparities across people of different ethnicities and deprivation. The overall purpose of this study is to provide an estimate of the lifetime risk of vitiligo in the population overall and by sociodemographic subgroups. Moreover, to do a subgroup analysis in the vitiligo population to identify health-related disparities across people in different sex, age, deprivation and ethnicity. A detailed understanding of the burden of disease in different sociodemographic groups is vital to plan resource provision.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVitiligo
CountriesUnited Kingdom
CollaboratorsPfizer

Timeline

N/ACompletedFinished
202420252026
First PostedOct 24, 2023
Enrollment StartJul 20, 2023
Primary CompletionJul 17, 2024
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 2.7 years ago

Interventions

No interventionother

Observational analysis of usual care only.